Treatment of pediatric localized scleroderma with methotrexate

Journal of Rheumatology

Volumn 33, Issue 3, 2006, Pages 609-614

  Fitch, Pamela G ^a   Rettig, Patricia ^b   Burnham, Jon M ^b   Finkel, Terri H ^b   Yan, Albert C ^c   Akin, Evren ^e   Cron, Randy Q ^d  

^a Department of Pediatrics ^*  (United States)

^b Division of Rheumatology   (United States)

^c Section of Pediatric Dermatology

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e GILLETTE CHILDREN'S SPECIALTY HEALTHCARE   (United States)

Author keywords

Child therapy; Corticosteroids; Localized scleroderma; Methotrexate

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; FLUOCINOLONE; FOLIC ACID; METHOTREXATE; NAPROXEN; PENICILLAMINE; PIMECROLIMUS; PSORALEN; TRIAMCINOLONE; TSUKUBAENOLIDE; VITAMIN D DERIVATIVE;

ADOLESCENT; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIVER DYSFUNCTION; LOCALIZED SCLERODERMA; MALE; MOOD DISORDER; PATIENT SATISFACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; METHOTREXATE; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; TREATMENT OUTCOME;

EID: 33644674246     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am 2002;28:603-24.
2. Foeldvari I, Wulffraat N. Recognition and management of scleroderma in children. Paediatr Drugs 2001;3:575-83.
3. Falanga V, Medsger TA Jr. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol 1990;126:609-12.
4. Peter RU, Ruzicka T, Eckert F. Low-dose cyclosporine A in the treatment of disabling morphea. Arch Dermatol 1991;127:1420-1.
5. Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994;130:663-4.
6. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998;39:220-5.
7. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998;38:21-6.
8. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000;16:43-9.
9. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 2000;80:26-7.
10. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36:938-44.
11. Grundmann-Kollmann M, Ochsendorf F, Zollner TM, et al. PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol 2000;43:675-8.
12. Morison WL. Psoralen UVA therapy for linear and generalized morphea. J Am Acad Dermatol 1997;37:657-9.
13. Hulshof MM, Pavel S, Breedveld FC, Dijkmans BA, Vermeer BJ. Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 1994;130:1290-3.
14. Elst EF, Van Suijlekom-Smit LW, Oranje AP. Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol 1999;16:53-8.
15. Humbert P, Aubin F, Dupond JL, Delaporte E. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma. Arch Dermatol 1995;131:850-1.
16. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998;39:211-5.
17. Kreuter A, Gambichler T, Avermaete A, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol 2001;18:241-5.
18. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000;136:91-5.
19. Walsh J, Matini F, Woo P. Evaluation and treatment of localized scleroderma in childhood [abstract]. Arch Dis Child 2000;82 Suppl:A44.
20. Seyger MM, van den Hoogen FH, van Vlijmen-Willems IM, van de Kerkhof PC, de long EM. Localized and systemic scleroderma show different histological responses to methotrexate therapy. J Pathol 2001;193:511-6.
21. Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005;141:847-52.
22. Martini G, Murray KJ, Howell KJ, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology Oxford 2002;41:1178-82.